Diane Harper – The full extent of the Gardasil scandal needs to be assessed: everyone knew when this vaccine was released on the American market that it would prove to be worthless

“The full extent of the Gardasil scandal needs to be assessed: everyone knew when this vaccine was released on the American market that it would prove to be worthless.  Diane Harper, a major opinion leader in the United States, was one of the first to blow the whistle, pointing out the fraud and scam of it all.I predict that Gardasil will become the greatest medical scandal of all time because at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill, serve no other purpose than to generate profit for the manufacturers. Gardasil is useless and costs a fortune!  In addition, decision-makers at all levels are aware of it! Cases of Guillain-Barré syndrome, paralysis of the lower limbs, vaccine-induced MS and vaccine-induced encephalitis can be found, whatever the vaccine.” (source) – Dr. Bernard Dalbergue

Dr. Bernard Dalbergue – Le Gardasil sera le plus grand scandale de tous les temps

Le Dr Bernard Dalbergue : “Les aspects négatifs de nos médicaments sont passés sous silence”

Dr. Bernard Dalbergue – Omerta dans les labos pharmaceutiques : Confessions d’un médecin

Clinical Review of Biologics License Application Supplement for Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant (Gardasil®) to extend indication for prevention of vaginal and  vulvar cancers related to HPV types 16 and 18.
The list below highlights some of the ‘New Medical Conditions’ reported in the 2008 FDA Closing Statement on Gardasil.
Blood & Lymphatic System Disorders 2.9% = 1 in 34
Gastrointestinal Disorders 13.4% = 1 in 7
General & Administration Site Conditions 3.8% = 1 in 33
Immune System Disorders 2.4% =1 in 50
Infections & Infestations 52.9% = 1 in 2
Injury, Poisoning, & Procedural Complications 8.0% =1 in 12
Investigations 11.8% =1 in 9
Musculoskeletal & Connective Tissue Disorders 6.8% =1 in 14
Nervous System Disorders 9.4% = 1 in 10
Pregnancy, Puerperium & Perinatal Conditions 2.0% = 1 in 50
Psychiatric Disorders 4.4% =1 in 22
Renal Disorders 2.7% =1 in 37
Reproductive & Brest Disorders 24.8 % = 1 in 14
Respiratory, Thoracic & Mediastinal Disorders 5.5% = 1 in 18
Skin & Subcutaneous Tissue Disorders 7.4% = 1 in 13
Surgical Procedures = Appendectomy 10.2% = 1 in 10
A year ago the vaccine was taken off the recommended vaccine schedule in Japan due to it’s adverse effects. What’s even more concerning is the fact that today’s vaccine has twice the amount of aluminum in it.

American College of Pediatricians Latest to Warn of Gardasil HPV Vaccine Dangers

Unconscionable Merck operative tried to bury scientific study revealing harm caused by Gardasil
It’s worth noting the highlights of the study, as reported by The Vaccine Reaction:
“In the study, researchers divided 76 female mice into four groups. The individual groups received injections of Gardasil; Gardasil plus pertussis toxin; aluminum adjuvant alone, or a ‘true’ placebo (as opposed to an aluminum-containing placebo typically used in Gardasil pre-licensure trials).
During three- and six-month observation periods, researchers found that compared with placebo-controlled mice, the mice injected with Gardasil or aluminum adjuvant spent significantly more time floating in the forced swimming test, which was a measure of depression used for rodents. After ruling out a connection between increased floating time and locomotor dysfunction through other testing, the researchers determined that these behavioral abnormalities were ‘likely due to depression.’
In maze tests, aluminum-injected mice also exhibited short-term memory impairment and increased anxiety compared with the placebo-controlled mice in other rodent tests. The research team concluded that Gardasil via its aluminum adjuvant and HPV antigens may “trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes.”

Results of a CDC-funded study entitled “A Clinical Analysis of Gelatin Allergy and Determination of its Causal Relationship to the Previous Administration of Gelatin-Containing Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids” concludes

Results of a CDC-funded study entitled “A Clinical Analysis of Gelatin Allergy and Determination of its Causal Relationship to the Previous Administration of Gelatin-Containing Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids” concludes:
“Most anaphylactic reactions and some urticarial reactions to gelatin-containing measles, mumps and rubella monovalent vaccines are associated with IgE-mediated gelatin allergy. DTaP immunization histories suggest that the gelatin-containing DTaP vaccine may have a causal relationship to the development of this gelatin allergy.”
Study: https://www.ncbi.nlm.nih.gov/pubmed/9949325
A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
RESULTS:
The 366 reported patients were categorized as follows: 34 with anaphylaxis, 76 with urticaria, 215 with nonurticarial generalized eruption, and 41 with local reactions only. In 206 patients from whom serum was available, IgE antibodies to gelatin were detected in 25 of 27 (93%) with anaphylaxis, 27 of 48 (56%) with urticaria, and 8 of 90 (9%) with a generalized eruption. None of a group of 41 patients with only local reactions at the injected site and none of a control group of 29 subjects with no adverse reaction had such antibodies. Among 202 patients for whom prior vaccine information was available, all had received DTaP vaccines. Among those for whom the prior DTaP vaccine could be determined to contain gelatin or be free of gelatin, 155 of 158 (98%) subjects had received gelatin-containing DTaP vaccines. This rate is higher than would be expected on the basis of the market share of gelatin-containing (vs gelatin-free) DTaP vaccines (75%). Furthermore, before 1993, when a trivalent measles, mumps, and rubella vaccine (with the same 0.2% gelatin content as the monovalent vaccines) was used and administered before DTaP vaccination, no reports of anaphylaxis to the measles, mumps, and rubella vaccine were received.
CONCLUSION:
Most anaphylactic reactions and some urticarial reactions to gelatin-containing measles, mumps, and rubella monovalent vaccines are associated with IgE-mediated gelatin allergy. DTaP immunization histories suggest that the gelatin-containing DTaP vaccine may have a causal relationship to the development of this gelatin allergy.

Gardasil HPV Vaccine Trial Using Infants as Young as One Year of Age

For years I have said the goal was to add Gardasil to the infant (vaccine) schedule. It appears that’s where we are headed.

This clinical trial will look at two of the four strains of HPV contained in the Quadrivalent Gardasil vaccine.

Read more at:
http://vaccineimpact.com/2016/gardasil-hpv-vaccine-trial-using-infants-as-young-as-one-year-of-age/
Clinical study:
https://clinicaltrials.gov/ct2/show/record/NCT01995721